Misuse and Addiction Prevention (OSMAP) is soliciting proposals for a contractor to develop, create, place, and provide comprehensive, statewide public education campaigns for its programs.
Additionally, the course should also address substance misuse prevention techniques for active duty military members who are “at risk” and who have been identified for screening as a result of an alcohol/drug incident, command referral, or self-referral. This should include both classroom instruction and clinic rotations, observation of individual or group sessions and residential facility tour.
Background: As part of its mission, The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), seeks to identify intervention strategies and leverage resilience to combat drug addiction.
The Bureau of Substance Addiction Services (BSAS) seeks proposals from existing Moms Do Care (MDC) programs sites to provide integrated, outpatient, substance use treatment medical home models to this expanded eligibility population (i.e., PPPW with substance misuse issues regardless of substance type).
Specifically, the SCTL aims to develop a renewable supply of human cell-based models focusing on new patient-derived iPSC lines that give rise to specialized, functional nerve cells that are relevant for opioid misuse, addiction, and pain.
The Massachusetts Department of Public Health (MDPH), Bureau of Substance Addiction Services (BSAS) announces the availability of funding as part of the Massachusetts Collaborative for Action, Leadership, and Learning 3 (MassCALL3) initiative to prevent substance misuse across the Commonwealth.
transmission of alerts regarding such potential misuse or abuse of opioids to prescribing physicians and dentists.Direct engagement with, education for, and management of beneficiaries under the TRICARE program to help such beneficiaries avoid misuse or abuse of opioid medications.Proactive outreach by specialist pharmacists to beneficiaries under the TRICARE program when\identifying potential misuse or abuse of opioid medications.Monitoring of beneficiaries
